Title : Di'ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway.

Pub. Date : 2022

PMID : 35571088






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 When ATO was combined with DXXK, the expression of LDLR was significantly increased and was higher than that of the model group and the expression of SREBP2 and PCSK9 in the liver was also significantly inhibited. Atorvastatin low density lipoprotein receptor Mus musculus